Temat: "bladder neoplasms" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer.
Autorzy:: Kim JS; Department of Applied Statistics, Chung-Ang University, Seoul, South Korea.
Lee J; Department of Applied Statistics, Chung-Ang University, Seoul, South Korea.
Nguyen TT; Department of Urology, Cho Ray Hospital, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Choi SY; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102, Heukseok-ro, Dongjak-gu, Seoul, 06973, South Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 10; Vol. 14 (1), pp. 8440. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Journal Article
MeSH Terms:: Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/pathology
Humans ; Follow-Up Studies ; Retrospective Studies ; Cystoscopy ; Disease Progression ; Neoplasm Recurrence, Local ; Neoplasm Invasiveness

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Office-based management of Non-Muscle Invasive Bladder Cancer (NMIBC): A position paper on current state of the art and future perspectives.
Autorzy:: Leonardi R; Casa di Cura Musumeci GECAS, Gravina di Catania; Urologi Ospedalità Gestione Privata (UrOP). .
Ambrosini F; IRCCS Policlinico San Martino, Genova. .
Cafarelli A; Urology Unit, Villa Igea, Ancona; Urologi Ospedalità Gestione Privata (UrOP). .
Calarco A; Villa Pia Hospital, Rome; Urologi Ospedalità Gestione Privata (UrOP). .
Colombo R; Department of Urology, Vita e Salute San Raffaele University, Milan; Urologi Ospedalità Gestione Privata (UrOP). .
Tuzzolo D; Urologi Ospedalità Gestione Privata (UrOP). .
De Marco F; I.N.I. Grottaferrata, Rome; Urologi Ospedalità Gestione Privata (UrOP). .
Ferrari G; Hesperia Hospital, Modena; Urologi Ospedalità Gestione Privata (UrOP). .
Ludovico G; Ospedale Miulli, Acquaviva delle Fonti, Bari; Urologi Ospedalità Gestione Privata (UrOP). .
Pecoraro S; NEUROMED, Avellino; Urologi Ospedalità Gestione Privata (UrOP). .
De Cobelli O; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan; Urologi Ospedalità Gestione Privata (UrOP). .
Terrone C; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova. .
Mantica G; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova. .; Pokaż więcej
Źródło:: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2024 Mar 19; Vol. 96 (1), pp. 12404. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/pathology
Humans ; Male ; Female ; Neoplasm Staging ; Neoplasm Invasiveness/pathology ; Risk Factors ; Neoplasm Recurrence, Local/therapy ; Neoplasm Recurrence, Local/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists.
Autorzy:: Moussa M; Department of Urology, Lebanese University, Beirut. .
Abou Chakra M; Department of Urology, Lebanese University, Beirut . .
Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC. .
Papatsoris A; Department of Urology, Lebanese University, Beirut. .
Farahat Y; Urology Department, Sheikh Khalifa General Hospital, Umm Al Quwain. .
O'Donnell MA; Department of Urology, University of Iowa, Iowa City, IA. .; Pokaż więcej
Źródło:: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2024 Mar 19; Vol. 96 (1), pp. 12244. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Humans ; Mitomycin/therapeutic use ; Gemcitabine ; BCG Vaccine/therapeutic use ; Urologists ; Docetaxel/therapeutic use ; Arabs ; Neoplasm Invasiveness ; Adjuvants, Immunologic/therapeutic use ; Neoplasm Recurrence, Local

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer.
Autorzy:: Lidagoster S; Department of Urology, Ichan School of Medicine at the Mount Sinai Hospital, New York, NY 10029, USA.; CUNY School of Medicine, City College of New York, New York, NY 10031, USA.
Ben-David R; Department of Urology, Ichan School of Medicine at the Mount Sinai Hospital, New York, NY 10029, USA.
De Leon B; Department of Urology, Ichan School of Medicine at the Mount Sinai Hospital, New York, NY 10029, USA.; SUNY Downstate Health Science University, New York, NY 11203, USA.
Sfakianos JP; Department of Urology, Ichan School of Medicine at the Mount Sinai Hospital, New York, NY 10029, USA.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 16; Vol. 31 (2), pp. 1063-1078. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/drug therapy
Complementary Therapies*
Humans ; BCG Vaccine/therapeutic use ; Mitomycin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: A systematic review and meta-analysis of intraarterial chemotherapy for non muscle invasive bladder cancer: Promising alternative therapy in high tuberculosis burden countries.
Autorzy:: Rahman ZA; Department of Urology, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General-Academic Hospital, Surabaya, East Java. .
Hidayatullah F; Department of Urology, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General-Academic Hospital, Surabaya, East Java. .
Lim J; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur. .
Hakim L; Department of Urology, Faculty of Medicine, Universitas Airlangga; Universitas Airlangga Teaching Hospital, Surabaya, East Java. .; Pokaż więcej
Źródło:: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2024 Feb 16; Vol. 96 (1), pp. 12154. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Tuberculosis*/drug therapy
Humans ; BCG Vaccine/therapeutic use ; Neoplasm Recurrence, Local ; Adjuvants, Immunologic/therapeutic use ; Neoplasm Invasiveness ; Observational Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
Autorzy:: Zhang C; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Xu X; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Wang T; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Lu Y; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Lu Z; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Wang T; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Pan Z; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China. pan_.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China. pan_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7941. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Carcinoma, Transitional Cell*/pathology
Humans ; Urinary Bladder/pathology ; Vimentin/genetics ; Biomarkers, Tumor/metabolism ; DNA Methylation/genetics ; Nuclear Proteins/genetics ; Twist-Related Protein 1/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Recurrent bladder leiomyoma: a case report.
Autorzy:: Yogeeta F; Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
Malik Z; Department of Urology, Liaquat National Hospital and Medical College, Karachi, Pakistan.
Rauf SA; Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan. .
Devi M; Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
Tooba F; Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
Jamalvi SA; Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
Rashid M; Department of Histopathology, Liaquat National Hospital and Medical College, Karachi, Pakistan.
Erum H; Department of Histopathology, Liaquat National Hospital and Medical College, Karachi, Pakistan.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Mar 22; Vol. 18 (1), pp. 173. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Leiomyoma*/diagnosis
Leiomyoma*/diagnostic imaging
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/diagnostic imaging
Kidney Neoplasms*/pathology
Lower Urinary Tract Symptoms*
Humans ; Female ; Aged ; Urinary Bladder/diagnostic imaging ; Urinary Bladder/surgery ; Urinary Bladder/pathology ; Hematuria

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
Autorzy:: Li L; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Jiang P; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Hu W; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Zou F; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Li M; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Rao T; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Ruan Y; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yu W; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Ning J; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. .
Cheng F; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 21; Vol. 22 (1), pp. 295. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: Tumor Suppressor Protein p53*/metabolism
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Animals ; Humans ; Mice ; Aurora Kinase B/genetics ; Aurora Kinase B/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; DNA Repair ; Gene Expression Regulation, Neoplastic ; Mad2 Proteins/genetics ; Mad2 Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial.
Autorzy:: Wu J; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Lin Y; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin, 300211, People's Republic of China.; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yang K; Department of Urology, Peking University First Hospital, No. 8 Xishiku Dajie, Xicheng District, Beijing, 100034, People's Republic of China.
Liu X; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
Wang H; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
Yu T; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
Tao R; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
Guo J; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
Chen L; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
Cheng H; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
Lou F; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China. .
Cao S; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China. .
Yu W; Department of Urology, Peking University First Hospital, No. 8 Xishiku Dajie, Xicheng District, Beijing, 100034, People's Republic of China. .
Hu H; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin, 300211, People's Republic of China. .; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. .
Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Mar 19; Vol. 23 (1), pp. 57. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Carcinoma, Transitional Cell*/diagnosis
Carcinoma, Transitional Cell*/genetics
Carcinoma, Transitional Cell*/urine
Humans ; Retrospective Studies ; Prospective Studies ; Sensitivity and Specificity ; Treatment Outcome ; DNA ; Biomarkers, Tumor/genetics ; Transcription Factors ; Homeodomain Proteins

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p/LRIG1 axis in bladder carcinoma.
Autorzy:: Cheng S; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan Xingqi Medical Laboratory Co., Ltd., 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China. .
Li C; Department of Digestive Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, 44 Xiaoheyan Road, ShenyangLiaoning, 110042, China.
Liu L; Department of Digestive Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, 44 Xiaoheyan Road, ShenyangLiaoning, 110042, China.
Liu X; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Li M; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Zhuo J; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Wang J; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Zheng W; Department of Emergency, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China. .
Wang Z; Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, 225 Changhai Road, Shanghai, 200000, China. .; Pokaż więcej
Źródło:: Biology direct [Biol Direct] 2024 Mar 07; Vol. 19 (1), pp. 20. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/pathology
Carcinoma*/genetics
Humans ; Urinary Bladder/metabolism ; Urinary Bladder/pathology ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Movement ; Gene Expression Regulation, Neoplastic ; Membrane Glycoproteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Comprehensive analysis of mitochondria-related genes indicates that PPP2R2B is a novel biomarker and promotes the progression of bladder cancer via Wnt signaling pathway.
Autorzy:: Shen D; College of Clinic Medical, North China University of Science and Technology, Tangshan, China.
Kang S; North China of Science and Technology Affiliated Hospital, Tangshan, China. .; Pokaż więcej
Źródło:: Biology direct [Biol Direct] 2024 Feb 26; Vol. 19 (1), pp. 17. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article
MeSH Terms:: Wnt Signaling Pathway*/genetics
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Male ; Humans ; Female ; Cell Line, Tumor ; Biomarkers ; Mitochondria/genetics ; Mitochondria/metabolism ; Gene Expression Regulation, Neoplastic ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; Protein Phosphatase 2/genetics ; Protein Phosphatase 2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation.
Autorzy:: Li T; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Huang M; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Sun N; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Hua X; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Chen R; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Xie Q; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Huang S; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Du M; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Zhao Y; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Lin Q; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Xu J; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Han X; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Zhao Y; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Tian Z; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Zhang Y; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Chen W; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China. .
Shen X; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China. .
Huang C; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 17; Vol. 43 (1), pp. 50. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: RNA, Long Noncoding*/genetics
Urinary Bladder Neoplasms*/chemically induced
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Animals ; Humans ; Mice ; Carcinogenesis/genetics ; Cell Proliferation ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Mice, Nude ; Muscles/metabolism ; Muscles/pathology ; Proteolysis ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism ; RNA, Messenger/metabolism ; Up-Regulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma.
Autorzy:: Zhang J; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yang M; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Wei D; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Zhang D; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Chen Z; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. .
Zhu H; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 13; Vol. 24 (1), pp. 202. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Transitional Cell*/drug therapy
Carcinoma, Transitional Cell*/surgery
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Antibodies, Monoclonal, Humanized*
Humans ; Cisplatin/therapeutic use ; Gemcitabine ; Retrospective Studies ; Deoxycytidine/adverse effects ; Muscles ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer.
Autorzy:: Torres-Bustamante MI; Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico.
Vazquez-Urrutia JR; Department of Medicine, The Pennsylvania State University College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA.
Solorzano-Ibarra F; Instituto de Investigación en Enfermedades Crónico Degenerativas, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico.; Estancias Posdoctorales por México, Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONACYT), México City 03940, Mexico.
Ortiz-Lazareno PC; División de Inmunología, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Mexico.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 11; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 11.
Typ publikacji:: Journal Article; Review
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Humans ; Gene Expression Profiling/methods ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer.
Autorzy:: Xie T; Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.; Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
Peng S; Department of Pathology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Liu S; Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Zheng M; Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Diao W; Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Ding M; Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Fu Y; Department of Pathology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Guo H; Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. .
Zhao W; Department of Clinical Biochemistry School of Laboratory Medicine/Sichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in Animal-Origin Food, Chengdu Medical College, No. 783, Xindu Rd, Chengdu, 610500, China. .
Zhuang J; Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. .; Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Feb 10; Vol. 23 (1), pp. 30. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: B7-H1 Antigen*/genetics
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Humans ; Prognosis ; Anoikis/genetics ; Disease Progression ; Immunotherapy ; Biomarkers ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis.
Autorzy:: Wang H; Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.; Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
Liu J; Medical Laboratory of Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Lou Y; Medical Laboratory of Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Liu Y; Department of Oncology, Yantian District People's Hospital, Shenzhen, China.
Chen J; Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.; Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
Liao X; Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.; Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
Zhang X; Medical Laboratory of Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Zhou C; Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Mei H; Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China. .; Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China. .
Tang A; Science and Educational Center of Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 02; Vol. 14 (1), pp. 2782. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder*/metabolism
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Humans ; Gene Regulatory Networks ; Gene Expression Profiling ; Neoplastic Processes ; Computational Biology ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1.
Autorzy:: Liu G; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Jin K; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Liu Z; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Su X; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Xu Z; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Li B; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Xu J; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Chang Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wang Y; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Xu L; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu J; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Wang Z; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Liu H; Department of Urology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang W; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e6962.
Typ publikacji:: Journal Article
MeSH Terms:: B7-H1 Antigen*/metabolism
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/metabolism
Humans ; Biomarkers ; Immunotherapy ; Chromosomal Instability ; Muscles/metabolism ; Muscles/pathology ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells.
Autorzy:: Li AH; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
Park SY; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
Li P; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
Zhou C; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
Kluz T; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
Li J; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
Costa M; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
Sun H; Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Stilbenes*/pharmacology
Humans ; Cell Line, Tumor ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Transcriptome ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
Autorzy:: Dong L; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Feng M; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kuczler MD; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Horie K; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kim CJ; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ma Z; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lombardo K; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Lyons H; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Amend SR; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kates M; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Bivalacqua TJ; Division of Urology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
McConkey D; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Xue W; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Choi W; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pienta KJ; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Pokaż więcej
Źródło:: Journal of extracellular vesicles [J Extracell Vesicles] 2024 Feb; Vol. 13 (2), pp. e12402.
Typ publikacji:: Journal Article
MeSH Terms:: Extracellular Vesicles*/genetics
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Humans ; Urinary Bladder ; Biomarkers, Tumor/genetics ; RNA, Messenger/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Xanthogranulomatous Ureteritis: A Diagnostic Challenge in a Patient with Bladder Cancer.
Autorzy:: Nova-Camacho LM; Department of Pathology, Donostia University Hospital, San Sebastian, Spain.
Val-Carreres Castellote A; Department of Pathology, Donostia University Hospital, San Sebastian, Spain.
Villafruela Mateos A; Department of Urology, Donostia University Hospital, San Sebastian, Spain.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 182-186. Date of Electronic Publication: 2023 May 04.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/complications
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/surgery
Carcinoma, Transitional Cell*/diagnosis
Carcinoma, Transitional Cell*/surgery
Carcinoma, Transitional Cell*/pathology
Ureter*/surgery
Ureter*/pathology
Urinary Tract Infections*/pathology
Gastrointestinal Diseases*/pathology
Male ; Humans ; Middle Aged ; Inflammation/pathology ; Granuloma/pathology ; Plasma Cells/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""bladder neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język